Context: Patents have been criticized in the developing world, as they are thought to reduce access to existing medicines. Reconciling patents and universal access to medicine would require an efficient international policy of price discrimination. Moreover, under the TRIPS agreement of the World Trade Organization, countries must allow pharmaceutical products to be patented. In 2001, the WTO adopted the Doha Declaration, which indicates that the TRIPS agreement should be read with the goals of public health in mind, and allows some methods for circumventing pharmaceutical monopolies: via compulsory licensing or parallel imports, even before patent expiration.

Question: Who adopted the Doha Declaration?
Answer: World Trade Organization

Question: What did the TRIPS agreement accomplish?
Answer: countries must allow pharmaceutical products to be patented

Question: Why are patents criticized?
Answer: thought to reduce access to existing medicines

Question: What did the Doha Declaration do?
Answer: indicates that the TRIPS agreement should be read with the goals of public health in mind, and allows some methods for circumventing pharmaceutical monopolies

Question: When was the Doha Declaration adopted?
Answer: 2001

Question: What has been accused of reducing access to medicines in developing countries?
Answer: Patents

Question: When did the World Trade Organization adopt the Doha Declaration?
Answer: 2001

Question: The Doha Declaration allows for what ways for monopolies to be bypassed?
Answer: compulsory licensing or parallel imports

Question: Who adopted the TRIPS Declaration?
Answer: Unanswerable

Question: What did the WTO agreement accomplish?
Answer: Unanswerable

Question: Why is the WTO criticized?
Answer: Unanswerable

Question: What did the WTO Declaration do?
Answer: Unanswerable

Question: When was the TRIPS Declaration adopted?
Answer: Unanswerable